EHRA Premium Access

New strategies for anticoagulation therapy after LAA closure

Congress Presentation

About the speaker

Professor Michael Glikson

Shaare Zedek Medical Center, Jerusalem (Israel)
21 presentations
1 follower

5 more presentations in this session

This session is supported by Abbott and Boston Scientific in the form of an educational grant. The scientific programme has not been influenced in any way by these sponsors.


Stroke prevention or bleeding: how to weigh the results of clinical trials

Speaker: Professor L. Boersma (Nieuwegein, NL)


The role of the LAA for AF and stroke: fact or fiction

Speaker: Professor T. Lewalter (Munich, DE)


LAA closure concomitant to AF ablation - The surgical perspective

Speaker: Associate Professor S. Salzberg (Zurich, CH)


LAA closure concomitant to AF ablation - The EP perspective

Speaker: Professor C. Tondo (Monzino, IT)


Access the full session

Novel insights of LAA treatment for atrial fibrillation and stroke prevention

Speakers: Professor M. Glikson, Professor L. Boersma, Professor T. Lewalter, Associate Professor S. Salzberg, Professor C. Tondo

About the event


EHRA 2018

18 March - 20 March 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb